Apyx Medical Corp — Director's Dealing 2021

Feb 12, 2021

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Apyx Medical Corp (APYX)
CIK: 0000719135
Period of Report: 2020-12-31

Reporting Person: Waldman Lawrence (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-06	Stock Option (Option to Buy)	$4.98	A	17000	Acquired	2030-08-06	Common Stock (17000.0)	Direct

Footnotes

F1: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.